img

Global Calcimimetic Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Calcimimetic Market Insights, Forecast to 2034

A calcimimetic is a pharmaceutical drug that mimics the action of calcium on tissues, by allosteric activation of the calcium-sensing receptor that is expressed in various human organ tissues. Calcimimetics are used to treat secondary hyperparathyroidism (SHPT).
Global Calcimimetic market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Calcimimetic industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
The parathyroid gland is an essential gland for human life, and SHPT is a common and serious decompensation disease in patients with chronic kidney disease receiving dialysis treatment, and it is one of the important manifestations of mineral metabolism disorders. According to the 2012 China Epidemiological Survey, the number of patients with middle and end-stage renal disease in China is about 2 million, the dialysis rate is less than 20%, and the conversion rate of SHPT in patients with mineral and bone metabolic disorders (CKD-MBD) is close to 50%. . The dialysis rate is 90% in developed countries (United States, Europe, Japan). Based on this, it can be predicted that in the future, the number of SHPT people will release a large growth space with the improvement of the diagnosis, detection and treatment of chronic kidney disease.
Report Covers
This report presents an overview of global Calcimimetic market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Calcimimetic market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Amgen
Ono Pharmaceutical
Aurobindo Pharma
Roche Holding AG
Lilly
Merck & Co., Inc.
Johnsons & Johnsons
Bristol Myers Squibb
Accord Healthcare , Inc.
Alkem Labs
Viatris
Teva Pharmaceutical Industries Ltd
Segment by Type
Cinacalcet
Etelcalcetide
Evocalcet

Segment by Application


Hospital
Clinic

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Calcimimetic plant distribution, commercial date of Calcimimetic, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Calcimimetic introduction, etc. Calcimimetic Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Calcimimetic
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Calcimimetic Product Introduction
1.2 Market by Type
1.2.1 Global Calcimimetic Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Cinacalcet
1.2.3 Etelcalcetide
1.2.4 Evocalcet
1.3 Market by Application
1.3.1 Global Calcimimetic Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Calcimimetic Sales Estimates and Forecasts 2018-2029
2.2 Global Calcimimetic Revenue by Region
2.2.1 Global Calcimimetic Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Calcimimetic Revenue by Region (2018-2024)
2.2.3 Global Calcimimetic Revenue by Region (2024-2029)
2.2.4 Global Calcimimetic Revenue Market Share by Region (2018-2029)
2.3 Global Calcimimetic Sales Estimates and Forecasts 2018-2029
2.4 Global Calcimimetic Sales by Region
2.4.1 Global Calcimimetic Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Calcimimetic Sales by Region (2018-2024)
2.4.3 Global Calcimimetic Sales by Region (2024-2029)
2.4.4 Global Calcimimetic Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Calcimimetic Sales by Manufacturers
3.1.1 Global Calcimimetic Sales by Manufacturers (2018-2024)
3.1.2 Global Calcimimetic Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Calcimimetic in 2022
3.2 Global Calcimimetic Revenue by Manufacturers
3.2.1 Global Calcimimetic Revenue by Manufacturers (2018-2024)
3.2.2 Global Calcimimetic Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Calcimimetic Revenue in 2022
3.3 Global Key Players of Calcimimetic, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Calcimimetic Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Calcimimetic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Calcimimetic, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Calcimimetic, Product Offered and Application
3.8 Global Key Manufacturers of Calcimimetic, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Calcimimetic Sales by Type
4.1.1 Global Calcimimetic Historical Sales by Type (2018-2024)
4.1.2 Global Calcimimetic Forecasted Sales by Type (2024-2029)
4.1.3 Global Calcimimetic Sales Market Share by Type (2018-2029)
4.2 Global Calcimimetic Revenue by Type
4.2.1 Global Calcimimetic Historical Revenue by Type (2018-2024)
4.2.2 Global Calcimimetic Forecasted Revenue by Type (2024-2029)
4.2.3 Global Calcimimetic Revenue Market Share by Type (2018-2029)
4.3 Global Calcimimetic Price by Type
4.3.1 Global Calcimimetic Price by Type (2018-2024)
4.3.2 Global Calcimimetic Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Calcimimetic Sales by Application
5.1.1 Global Calcimimetic Historical Sales by Application (2018-2024)
5.1.2 Global Calcimimetic Forecasted Sales by Application (2024-2029)
5.1.3 Global Calcimimetic Sales Market Share by Application (2018-2029)
5.2 Global Calcimimetic Revenue by Application
5.2.1 Global Calcimimetic Historical Revenue by Application (2018-2024)
5.2.2 Global Calcimimetic Forecasted Revenue by Application (2024-2029)
5.2.3 Global Calcimimetic Revenue Market Share by Application (2018-2029)
5.3 Global Calcimimetic Price by Application
5.3.1 Global Calcimimetic Price by Application (2018-2024)
5.3.2 Global Calcimimetic Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Calcimimetic Market Size by Type
6.1.1 US & Canada Calcimimetic Sales by Type (2018-2029)
6.1.2 US & Canada Calcimimetic Revenue by Type (2018-2029)
6.2 US & Canada Calcimimetic Market Size by Application
6.2.1 US & Canada Calcimimetic Sales by Application (2018-2029)
6.2.2 US & Canada Calcimimetic Revenue by Application (2018-2029)
6.3 US & Canada Calcimimetic Market Size by Country
6.3.1 US & Canada Calcimimetic Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Calcimimetic Sales by Country (2018-2029)
6.3.3 US & Canada Calcimimetic Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Calcimimetic Market Size by Type
7.1.1 Europe Calcimimetic Sales by Type (2018-2029)
7.1.2 Europe Calcimimetic Revenue by Type (2018-2029)
7.2 Europe Calcimimetic Market Size by Application
7.2.1 Europe Calcimimetic Sales by Application (2018-2029)
7.2.2 Europe Calcimimetic Revenue by Application (2018-2029)
7.3 Europe Calcimimetic Market Size by Country
7.3.1 Europe Calcimimetic Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Calcimimetic Sales by Country (2018-2029)
7.3.3 Europe Calcimimetic Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Calcimimetic Market Size
8.1.1 China Calcimimetic Sales (2018-2029)
8.1.2 China Calcimimetic Revenue (2018-2029)
8.2 China Calcimimetic Market Size by Application
8.2.1 China Calcimimetic Sales by Application (2018-2029)
8.2.2 China Calcimimetic Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Calcimimetic Market Size by Type
9.1.1 Asia Calcimimetic Sales by Type (2018-2029)
9.1.2 Asia Calcimimetic Revenue by Type (2018-2029)
9.2 Asia Calcimimetic Market Size by Application
9.2.1 Asia Calcimimetic Sales by Application (2018-2029)
9.2.2 Asia Calcimimetic Revenue by Application (2018-2029)
9.3 Asia Calcimimetic Sales by Region
9.3.1 Asia Calcimimetic Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Calcimimetic Revenue by Region (2018-2029)
9.3.3 Asia Calcimimetic Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Calcimimetic Market Size by Type
10.1.1 Middle East, Africa and Latin America Calcimimetic Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Calcimimetic Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Calcimimetic Market Size by Application
10.2.1 Middle East, Africa and Latin America Calcimimetic Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Calcimimetic Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Calcimimetic Sales by Country
10.3.1 Middle East, Africa and Latin America Calcimimetic Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Calcimimetic Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Calcimimetic Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Amgen
11.1.1 Amgen Company Information
11.1.2 Amgen Overview
11.1.3 Amgen Calcimimetic Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Amgen Calcimimetic Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Amgen Recent Developments
11.2 Ono Pharmaceutical
11.2.1 Ono Pharmaceutical Company Information
11.2.2 Ono Pharmaceutical Overview
11.2.3 Ono Pharmaceutical Calcimimetic Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Ono Pharmaceutical Calcimimetic Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Ono Pharmaceutical Recent Developments
11.3 Aurobindo Pharma
11.3.1 Aurobindo Pharma Company Information
11.3.2 Aurobindo Pharma Overview
11.3.3 Aurobindo Pharma Calcimimetic Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Aurobindo Pharma Calcimimetic Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Aurobindo Pharma Recent Developments
11.4 Roche Holding AG
11.4.1 Roche Holding AG Company Information
11.4.2 Roche Holding AG Overview
11.4.3 Roche Holding AG Calcimimetic Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Roche Holding AG Calcimimetic Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Roche Holding AG Recent Developments
11.5 Lilly
11.5.1 Lilly Company Information
11.5.2 Lilly Overview
11.5.3 Lilly Calcimimetic Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Lilly Calcimimetic Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Lilly Recent Developments
11.6 Merck & Co., Inc.
11.6.1 Merck & Co., Inc. Company Information
11.6.2 Merck & Co., Inc. Overview
11.6.3 Merck & Co., Inc. Calcimimetic Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Merck & Co., Inc. Calcimimetic Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Merck & Co., Inc. Recent Developments
11.7 Johnsons & Johnsons
11.7.1 Johnsons & Johnsons Company Information
11.7.2 Johnsons & Johnsons Overview
11.7.3 Johnsons & Johnsons Calcimimetic Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Johnsons & Johnsons Calcimimetic Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Johnsons & Johnsons Recent Developments
11.8 Bristol Myers Squibb
11.8.1 Bristol Myers Squibb Company Information
11.8.2 Bristol Myers Squibb Overview
11.8.3 Bristol Myers Squibb Calcimimetic Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Bristol Myers Squibb Calcimimetic Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bristol Myers Squibb Recent Developments
11.9 Accord Healthcare , Inc.
11.9.1 Accord Healthcare , Inc. Company Information
11.9.2 Accord Healthcare , Inc. Overview
11.9.3 Accord Healthcare , Inc. Calcimimetic Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Accord Healthcare , Inc. Calcimimetic Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Accord Healthcare , Inc. Recent Developments
11.10 Alkem Labs
11.10.1 Alkem Labs Company Information
11.10.2 Alkem Labs Overview
11.10.3 Alkem Labs Calcimimetic Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Alkem Labs Calcimimetic Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Alkem Labs Recent Developments
11.11 Viatris
11.11.1 Viatris Company Information
11.11.2 Viatris Overview
11.11.3 Viatris Calcimimetic Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Viatris Calcimimetic Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Viatris Recent Developments
11.12 Teva Pharmaceutical Industries Ltd
11.12.1 Teva Pharmaceutical Industries Ltd Company Information
11.12.2 Teva Pharmaceutical Industries Ltd Overview
11.12.3 Teva Pharmaceutical Industries Ltd Calcimimetic Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Teva Pharmaceutical Industries Ltd Calcimimetic Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Teva Pharmaceutical Industries Ltd Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Calcimimetic Industry Chain Analysis
12.2 Calcimimetic Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Calcimimetic Production Mode & Process
12.4 Calcimimetic Sales and Marketing
12.4.1 Calcimimetic Sales Channels
12.4.2 Calcimimetic Distributors
12.5 Calcimimetic Customers
13 Market Dynamics
13.1 Calcimimetic Industry Trends
13.2 Calcimimetic Market Drivers
13.3 Calcimimetic Market Challenges
13.4 Calcimimetic Market Restraints
14 Key Findings in The Global Calcimimetic Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Calcimimetic Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Cinacalcet
Table 3. Major Manufacturers of Etelcalcetide
Table 4. Major Manufacturers of Evocalcet
Table 5. Global Calcimimetic Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Calcimimetic Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Calcimimetic Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global Calcimimetic Revenue by Region (2024-2029) & (US$ Million)
Table 9. Global Calcimimetic Revenue Market Share by Region (2018-2024)
Table 10. Global Calcimimetic Revenue Market Share by Region (2024-2029)
Table 11. Global Calcimimetic Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 12. Global Calcimimetic Sales by Region (2018-2024) & (K Units)
Table 13. Global Calcimimetic Sales by Region (2024-2029) & (K Units)
Table 14. Global Calcimimetic Sales Market Share by Region (2018-2024)
Table 15. Global Calcimimetic Sales Market Share by Region (2024-2029)
Table 16. Global Calcimimetic Sales by Manufacturers (2018-2024) & (K Units)
Table 17. Global Calcimimetic Sales Share by Manufacturers (2018-2024)
Table 18. Global Calcimimetic Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global Calcimimetic Revenue Share by Manufacturers (2018-2024)
Table 20. Global Key Players of Calcimimetic, Industry Ranking, 2021 VS 2022 VS 2024
Table 21. Calcimimetic Price by Manufacturers 2018-2024 (US$/Unit)
Table 22. Global Calcimimetic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Calcimimetic by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Calcimimetic as of 2022)
Table 24. Global Key Manufacturers of Calcimimetic, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of Calcimimetic, Product Offered and Application
Table 26. Global Key Manufacturers of Calcimimetic, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Calcimimetic Sales by Type (2018-2024) & (K Units)
Table 29. Global Calcimimetic Sales by Type (2024-2029) & (K Units)
Table 30. Global Calcimimetic Sales Share by Type (2018-2024)
Table 31. Global Calcimimetic Sales Share by Type (2024-2029)
Table 32. Global Calcimimetic Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global Calcimimetic Revenue by Type (2024-2029) & (US$ Million)
Table 34. Global Calcimimetic Revenue Share by Type (2018-2024)
Table 35. Global Calcimimetic Revenue Share by Type (2024-2029)
Table 36. Calcimimetic Price by Type (2018-2024) & (US$/Unit)
Table 37. Global Calcimimetic Price Forecast by Type (2024-2029) & (US$/Unit)
Table 38. Global Calcimimetic Sales by Application (2018-2024) & (K Units)
Table 39. Global Calcimimetic Sales by Application (2024-2029) & (K Units)
Table 40. Global Calcimimetic Sales Share by Application (2018-2024)
Table 41. Global Calcimimetic Sales Share by Application (2024-2029)
Table 42. Global Calcimimetic Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global Calcimimetic Revenue by Application (2024-2029) & (US$ Million)
Table 44. Global Calcimimetic Revenue Share by Application (2018-2024)
Table 45. Global Calcimimetic Revenue Share by Application (2024-2029)
Table 46. Calcimimetic Price by Application (2018-2024) & (US$/Unit)
Table 47. Global Calcimimetic Price Forecast by Application (2024-2029) & (US$/Unit)
Table 48. US & Canada Calcimimetic Sales by Type (2018-2024) & (K Units)
Table 49. US & Canada Calcimimetic Sales by Type (2024-2029) & (K Units)
Table 50. US & Canada Calcimimetic Revenue by Type (2018-2024) & (US$ Million)
Table 51. US & Canada Calcimimetic Revenue by Type (2024-2029) & (US$ Million)
Table 52. US & Canada Calcimimetic Sales by Application (2018-2024) & (K Units)
Table 53. US & Canada Calcimimetic Sales by Application (2024-2029) & (K Units)
Table 54. US & Canada Calcimimetic Revenue by Application (2018-2024) & (US$ Million)
Table 55. US & Canada Calcimimetic Revenue by Application (2024-2029) & (US$ Million)
Table 56. US & Canada Calcimimetic Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 57. US & Canada Calcimimetic Revenue by Country (2018-2024) & (US$ Million)
Table 58. US & Canada Calcimimetic Revenue by Country (2024-2029) & (US$ Million)
Table 59. US & Canada Calcimimetic Sales by Country (2018-2024) & (K Units)
Table 60. US & Canada Calcimimetic Sales by Country (2024-2029) & (K Units)
Table 61. Europe Calcimimetic Sales by Type (2018-2024) & (K Units)
Table 62. Europe Calcimimetic Sales by Type (2024-2029) & (K Units)
Table 63. Europe Calcimimetic Revenue by Type (2018-2024) & (US$ Million)
Table 64. Europe Calcimimetic Revenue by Type (2024-2029) & (US$ Million)
Table 65. Europe Calcimimetic Sales by Application (2018-2024) & (K Units)
Table 66. Europe Calcimimetic Sales by Application (2024-2029) & (K Units)
Table 67. Europe Calcimimetic Revenue by Application (2018-2024) & (US$ Million)
Table 68. Europe Calcimimetic Revenue by Application (2024-2029) & (US$ Million)
Table 69. Europe Calcimimetic Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 70. Europe Calcimimetic Revenue by Country (2018-2024) & (US$ Million)
Table 71. Europe Calcimimetic Revenue by Country (2024-2029) & (US$ Million)
Table 72. Europe Calcimimetic Sales by Country (2018-2024) & (K Units)
Table 73. Europe Calcimimetic Sales by Country (2024-2029) & (K Units)
Table 74. China Calcimimetic Sales by Type (2018-2024) & (K Units)
Table 75. China Calcimimetic Sales by Type (2024-2029) & (K Units)
Table 76. China Calcimimetic Revenue by Type (2018-2024) & (US$ Million)
Table 77. China Calcimimetic Revenue by Type (2024-2029) & (US$ Million)
Table 78. China Calcimimetic Sales by Application (2018-2024) & (K Units)
Table 79. China Calcimimetic Sales by Application (2024-2029) & (K Units)
Table 80. China Calcimimetic Revenue by Application (2018-2024) & (US$ Million)
Table 81. China Calcimimetic Revenue by Application (2024-2029) & (US$ Million)
Table 82. Asia Calcimimetic Sales by Type (2018-2024) & (K Units)
Table 83. Asia Calcimimetic Sales by Type (2024-2029) & (K Units)
Table 84. Asia Calcimimetic Revenue by Type (2018-2024) & (US$ Million)
Table 85. Asia Calcimimetic Revenue by Type (2024-2029) & (US$ Million)
Table 86. Asia Calcimimetic Sales by Application (2018-2024) & (K Units)
Table 87. Asia Calcimimetic Sales by Application (2024-2029) & (K Units)
Table 88. Asia Calcimimetic Revenue by Application (2018-2024) & (US$ Million)
Table 89. Asia Calcimimetic Revenue by Application (2024-2029) & (US$ Million)
Table 90. Asia Calcimimetic Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 91. Asia Calcimimetic Revenue by Region (2018-2024) & (US$ Million)
Table 92. Asia Calcimimetic Revenue by Region (2024-2029) & (US$ Million)
Table 93. Asia Calcimimetic Sales by Region (2018-2024) & (K Units)
Table 94. Asia Calcimimetic Sales by Region (2024-2029) & (K Units)
Table 95. Middle East, Africa and Latin America Calcimimetic Sales by Type (2018-2024) & (K Units)
Table 96. Middle East, Africa and Latin America Calcimimetic Sales by Type (2024-2029) & (K Units)
Table 97. Middle East, Africa and Latin America Calcimimetic Revenue by Type (2018-2024) & (US$ Million)
Table 98. Middle East, Africa and Latin America Calcimimetic Revenue by Type (2024-2029) & (US$ Million)
Table 99. Middle East, Africa and Latin America Calcimimetic Sales by Application (2018-2024) & (K Units)
Table 100. Middle East, Africa and Latin America Calcimimetic Sales by Application (2024-2029) & (K Units)
Table 101. Middle East, Africa and Latin America Calcimimetic Revenue by Application (2018-2024) & (US$ Million)
Table 102. Middle East, Africa and Latin America Calcimimetic Revenue by Application (2024-2029) & (US$ Million)
Table 103. Middle East, Africa and Latin America Calcimimetic Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 104. Middle East, Africa and Latin America Calcimimetic Revenue by Country (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America Calcimimetic Revenue by Country (2024-2029) & (US$ Million)
Table 106. Middle East, Africa and Latin America Calcimimetic Sales by Country (2018-2024) & (K Units)
Table 107. Middle East, Africa and Latin America Calcimimetic Sales by Country (2024-2029) & (K Units)
Table 108. Amgen Company Information
Table 109. Amgen Description and Major Businesses
Table 110. Amgen Calcimimetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 111. Amgen Calcimimetic Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Amgen Recent Developments
Table 113. Ono Pharmaceutical Company Information
Table 114. Ono Pharmaceutical Description and Major Businesses
Table 115. Ono Pharmaceutical Calcimimetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 116. Ono Pharmaceutical Calcimimetic Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Ono Pharmaceutical Recent Developments
Table 118. Aurobindo Pharma Company Information
Table 119. Aurobindo Pharma Description and Major Businesses
Table 120. Aurobindo Pharma Calcimimetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 121. Aurobindo Pharma Calcimimetic Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Aurobindo Pharma Recent Developments
Table 123. Roche Holding AG Company Information
Table 124. Roche Holding AG Description and Major Businesses
Table 125. Roche Holding AG Calcimimetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 126. Roche Holding AG Calcimimetic Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Roche Holding AG Recent Developments
Table 128. Lilly Company Information
Table 129. Lilly Description and Major Businesses
Table 130. Lilly Calcimimetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 131. Lilly Calcimimetic Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Lilly Recent Developments
Table 133. Merck & Co., Inc. Company Information
Table 134. Merck & Co., Inc. Description and Major Businesses
Table 135. Merck & Co., Inc. Calcimimetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 136. Merck & Co., Inc. Calcimimetic Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Merck & Co., Inc. Recent Developments
Table 138. Johnsons & Johnsons Company Information
Table 139. Johnsons & Johnsons Description and Major Businesses
Table 140. Johnsons & Johnsons Calcimimetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 141. Johnsons & Johnsons Calcimimetic Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. Johnsons & Johnsons Recent Developments
Table 143. Bristol Myers Squibb Company Information
Table 144. Bristol Myers Squibb Description and Major Businesses
Table 145. Bristol Myers Squibb Calcimimetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 146. Bristol Myers Squibb Calcimimetic Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Bristol Myers Squibb Recent Developments
Table 148. Accord Healthcare , Inc. Company Information
Table 149. Accord Healthcare , Inc. Description and Major Businesses
Table 150. Accord Healthcare , Inc. Calcimimetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 151. Accord Healthcare , Inc. Calcimimetic Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. Accord Healthcare , Inc. Recent Developments
Table 153. Alkem Labs Company Information
Table 154. Alkem Labs Description and Major Businesses
Table 155. Alkem Labs Calcimimetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 156. Alkem Labs Calcimimetic Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Alkem Labs Recent Developments
Table 158. Viatris Company Information
Table 159. Viatris Description and Major Businesses
Table 160. Viatris Calcimimetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 161. Viatris Calcimimetic Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. Viatris Recent Developments
Table 163. Teva Pharmaceutical Industries Ltd Company Information
Table 164. Teva Pharmaceutical Industries Ltd Description and Major Businesses
Table 165. Teva Pharmaceutical Industries Ltd Calcimimetic Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 166. Teva Pharmaceutical Industries Ltd Calcimimetic Product Model Numbers, Pictures, Descriptions and Specifications
Table 167. Teva Pharmaceutical Industries Ltd Recent Developments
Table 168. Key Raw Materials Lists
Table 169. Raw Materials Key Suppliers Lists
Table 170. Calcimimetic Distributors List
Table 171. Calcimimetic Customers List
Table 172. Calcimimetic Market Trends
Table 173. Calcimimetic Market Drivers
Table 174. Calcimimetic Market Challenges
Table 175. Calcimimetic Market Restraints
Table 176. Research Programs/Design for This Report
Table 177. Key Data Information from Secondary Sources
Table 178. Key Data Information from Primary Sources
List of Figures
Figure 1. Calcimimetic Product Picture
Figure 2. Global Calcimimetic Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Calcimimetic Market Share by Type in 2022 & 2029
Figure 4. Cinacalcet Product Picture
Figure 5. Etelcalcetide Product Picture
Figure 6. Evocalcet Product Picture
Figure 7. Global Calcimimetic Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Calcimimetic Market Share by Application in 2022 & 2029
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Calcimimetic Report Years Considered
Figure 12. Global Calcimimetic Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Calcimimetic Revenue 2018-2029 (US$ Million)
Figure 14. Global Calcimimetic Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Calcimimetic Revenue Market Share by Region (2018-2029)
Figure 16. Global Calcimimetic Sales 2018-2029 ((K Units)
Figure 17. Global Calcimimetic Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Calcimimetic Sales YoY (2018-2029) & (K Units)
Figure 19. US & Canada Calcimimetic Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Calcimimetic Sales YoY (2018-2029) & (K Units)
Figure 21. Europe Calcimimetic Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Calcimimetic Sales YoY (2018-2029) & (K Units)
Figure 23. China Calcimimetic Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Calcimimetic Sales YoY (2018-2029) & (K Units)
Figure 25. Asia (excluding China) Calcimimetic Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Calcimimetic Sales YoY (2018-2029) & (K Units)
Figure 27. Middle East, Africa and Latin America Calcimimetic Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Calcimimetic Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Calcimimetic in the World: Market Share by Calcimimetic Revenue in 2022
Figure 30. Global Calcimimetic Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Calcimimetic Sales Market Share by Type (2018-2029)
Figure 32. Global Calcimimetic Revenue Market Share by Type (2018-2029)
Figure 33. Global Calcimimetic Sales Market Share by Application (2018-2029)
Figure 34. Global Calcimimetic Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Calcimimetic Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Calcimimetic Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Calcimimetic Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Calcimimetic Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Calcimimetic Revenue Share by Country (2018-2029)
Figure 40. US & Canada Calcimimetic Sales Share by Country (2018-2029)
Figure 41. U.S. Calcimimetic Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Calcimimetic Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Calcimimetic Sales Market Share by Type (2018-2029)
Figure 44. Europe Calcimimetic Revenue Market Share by Type (2018-2029)
Figure 45. Europe Calcimimetic Sales Market Share by Application (2018-2029)
Figure 46. Europe Calcimimetic Revenue Market Share by Application (2018-2029)
Figure 47. Europe Calcimimetic Revenue Share by Country (2018-2029)
Figure 48. Europe Calcimimetic Sales Share by Country (2018-2029)
Figure 49. Germany Calcimimetic Revenue (2018-2029) & (US$ Million)
Figure 50. France Calcimimetic Revenue (2018-2029) & (US$ Million)
Figure 51. U.K. Calcimimetic Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Calcimimetic Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Calcimimetic Revenue (2018-2029) & (US$ Million)
Figure 54. China Calcimimetic Sales Market Share by Type (2018-2029)
Figure 55. China Calcimimetic Revenue Market Share by Type (2018-2029)
Figure 56. China Calcimimetic Sales Market Share by Application (2018-2029)
Figure 57. China Calcimimetic Revenue Market Share by Application (2018-2029)
Figure 58. Asia Calcimimetic Sales Market Share by Type (2018-2029)
Figure 59. Asia Calcimimetic Revenue Market Share by Type (2018-2029)
Figure 60. Asia Calcimimetic Sales Market Share by Application (2018-2029)
Figure 61. Asia Calcimimetic Revenue Market Share by Application (2018-2029)
Figure 62. Asia Calcimimetic Revenue Share by Region (2018-2029)
Figure 63. Asia Calcimimetic Sales Share by Region (2018-2029)
Figure 64. Japan Calcimimetic Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Calcimimetic Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Calcimimetic Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Calcimimetic Revenue (2018-2029) & (US$ Million)
Figure 68. India Calcimimetic Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Calcimimetic Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Calcimimetic Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Calcimimetic Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Calcimimetic Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Calcimimetic Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Calcimimetic Sales Share by Country (2018-2029)
Figure 75. Brazil Calcimimetic Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Calcimimetic Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Calcimimetic Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Calcimimetic Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Calcimimetic Revenue (2018-2029) & (US$ Million)
Figure 80. Calcimimetic Value Chain
Figure 81. Calcimimetic Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed